Tag - takeda

 
 

TAKEDA

Japan Times
JAPAN
Mar 5, 2021
Japan's Takeda seeks government approval for Moderna COVID-19 vaccine
While awaiting regulatory approval, Takeda plans to start distributing the Moderna vaccine in the first half of this year.
Japan Times
BUSINESS
Nov 20, 2020
‘Selling dog as mutton’: Mobile carriers dip on minister’s rebuke
Shares in some of the country’s largest mobile phone carriers dropped in Tokyo after the communications minister accused the companies of deploying a bait-and-switch tactic in cutting the costs of mobile phone plans.
Japan Times
BUSINESS / Companies
Aug 24, 2020
Takeda to sell consumer unit to Blackstone for ¥242 billion
Takeda Pharmaceutical Co. agreed to sell its Japanese consumer health care business for ¥242 billion ($2.3 billion) to Blackstone Group Inc., which plans to take the over-the-counter medication unit public in about five years.
Japan Times
BUSINESS / Companies
Jul 31, 2020
Taisho emerges as lead bidder for Takeda $3 billion consumer unit
Taisho Pharmaceutical Holdings Co. has emerged as the leading contender to acquire Takeda Pharmaceutical Co.’s Japanese consumer health care business, according to people familiar with the matter.
Japan Times
BUSINESS
Mar 4, 2020
Japan's largest drugmaker working to develop virus treatment, Dow Jones reports
Takeda Pharmaceutical Co. is developing an experimental therapy for the novel coronavirus with the goal of making it available in 9 to 18 months, the nation's largest drugmaker said.
Japan Times
BUSINESS / Companies
Feb 20, 2020
As COVID-19 spreads, Takeda CEO urges more industry investment in vaccines
The spread of novel coronavirus infections is starting to make one thing clear: More vaccine investment is needed, the CEO of Asia's biggest drugmaker said.
Japan Times
JAPAN / Science & Health
Nov 7, 2019
Takeda's dengue vaccine said effective overall in study but with major limitation
Takeda Pharmaceutical Co.'s experimental dengue vaccine was highly effective at preventing the mosquito-borne disease in a late stage study, but it failed to protect against one type of the virus in people with no prior exposure to dengue.
Japan Times
BUSINESS / Companies
Oct 11, 2019
Takeda nears deal on sale of Russia, Mideast and Africa assets to private equity firms
Takeda Pharmaceutical Co. is nearing the sale of a portfolio of assets in the Middle East, Africa and Russia to separate buyout firms that could help the drugmaker raise about $1 billion to reduce debt, according to people familiar with the matter.
Japan Times
JAPAN
Oct 1, 2019
National Public Safety Commission tackles topics from elderly driving to Tokyo Olympics security
The government will consider various measures to prevent traffic accidents involving elderly drivers, including the introduction of a new driver's license category with special limitations, National Public Safety Commission Chairman Ryota Takeda has said.
Japan Times
BUSINESS / Companies
Sep 27, 2019
Takeda Pharmaceutical to sell drug assets in emerging markets and Europe, sources say
Takeda Pharmaceutical Co. is close to selling some assets in emerging markets and Western Europe, people familiar with the matter said, in a move that would help the Japanese drugmaker reduce its debt pile.
Japan Times
OLYMPICS
Aug 28, 2019
French investigators focus on Dentsu partner in sports corruption probe
French authorities investigating corruption in international sports believe a Swiss partner of Japanese advertising giant Dentsu Inc. played a "central and essential role" in deals used to embezzle sponsorship money and have asked Switzerland to raid its office and seize evidence, according to a person...
Japan Times
OLYMPICS
Jun 27, 2019
Judo great Yasuhiro Yamashita replaces scandal-hit Tsunekazu Takeda as Japanese Olympic Committee chief
Yamashita will replace Tsunekazu Takeda who retired as JOC president amid an investigation over alleged bribery during Tokyo's bid to host the Tokyo 2020 Olympic and Paralympic Games.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?